TriCombo
- Composition
- Hyaluronic acid, chondroitin sulfate and N-acetylglucosamine
- Treatment aim
- Joint-fluid supplementation

London Cartilage Clinic · The TriCombo guide
Compare Bioport TriCombo with hyaluronic acid, Arthrosamid, ChondroFiller and Mytocel, and understand how different approaches fit different knee problems.
At a glance
Knee injections are often discussed as though they were versions of the same treatment. In practice, they can contain very different materials and be intended for different clinical aims. A joint-fluid supplement, a hydrogel implant, a collagen scaffold and a patient-derived preparation are distinct approaches.
The comparison begins with your diagnosis and the outcome you want: managing osteoarthritis symptoms, addressing a cartilage defect or exploring a particular joint-preservation strategy. This guide explains where TriCombo sits in that conversation and links to the individual treatment hubs for greater detail.
Compare what each approach is intended to do. These are not interchangeable treatments, and this is not a head-to-head effectiveness ranking.
TriCombo belongs in the joint-fluid supplementation discussion, but its formulation combines hyaluronic acid with chondroitin sulfate and N-acetylglucosamine. Bioport also describes physical association between its polymers as a feature of the product design.
When comparing it with another hyaluronic acid injection, look beyond the shared ingredient name. The formulation, treatment schedule, supporting research and reason for recommending the product all matter. Ask the clinician to explain which features are relevant to your knee and how the response will be assessed. The presence of additional ingredients is a formulation difference, not by itself a head-to-head result.
Arthrosamid is a non-absorbable polyacrylamide hydrogel implant used for symptomatic knee osteoarthritis. TriCombo is a different formulation centred on hyaluronate with chondroitin sulfate and NAG. Their materials, proposed mechanisms and evidence should therefore be considered separately.
A useful consultation compares the options through the same practical questions: suitability for your diagnosis, what the procedure involves, the expected treatment goal, follow-up and cost. If you have already received a hydrogel implant or another joint injection, make sure the clinician knows the product and date before planning further treatment.
ChondroFiller uses a collagen scaffold approach to cartilage treatment. It is not another version of a joint-fluid supplement. The location and pattern of cartilage damage, the joint involved and the intended technique are important to that discussion.
This is why choosing between brands is not the first step. A person looking for symptom management in an arthritic knee may have a different treatment aim from someone being assessed for a defined cartilage defect. The ChondroFiller hub explains its own pathway; your assessment can establish which type of approach is relevant to the findings in your knee.
Mytocel uses patient-derived cartilage micrografts, introducing a different preparation and procedural pathway from a pre-filled combination injection. For patients, that means the comparison includes both the treatment rationale and what happens during the appointment.
Discuss the proposed source and preparation of any patient-derived material, the injection procedure and the follow-up plan. The Mytocel guide provides the detail for that approach. TriCombo’s pre-filled formulation can then be considered on its own terms, alongside the other options that are clinically relevant.
05 · Your TriCombo guide
The product is only one part of a treatment decision. Compare the assessment, the procedure, any imaging, aftercare and review arrangements as well. A clear written quotation should identify what is included, especially if more than one knee or more than one appointment is being discussed.
Consider the practical demands of work, travel and rehabilitation. A treatment plan that is easy to understand and realistic to follow is more useful than a list of brand names. Your clinician can explain which differences matter for your knee and which are less relevant to the decision.

06 · Your TriCombo guide
There may be several reasonable questions to explore rather than one obvious product to choose. You may value a particular treatment format, want to understand the research, or need to plan around a demanding schedule. Explain those priorities at the beginning.
LCC can review your previous treatments and imaging alongside the activities you want to improve. The aim is a recommendation with a clear clinical reason, a practical plan and an agreed way to review the result. Start with a discovery call if you would like help arranging that assessment.
Read the original documents
Take a closer look at the formulation and product information before your consultation.

No. It contains hyaluronic acid, chondroitin sulfate and N-acetylglucosamine rather than a corticosteroid.
No. Arthrosamid is a non-absorbable polyacrylamide hydrogel implant. TriCombo has a different composition and formulation.
A combination provides a different formulation and rationale. The recommendation should also consider the clinical evidence, your diagnosis and the treatment goal.
This needs a specific clinical review. Tell the team about earlier injections and implants so the clinician can consider product instructions and your individual treatment history.
Ask for written quotations that identify the consultation, procedure, product, imaging and follow-up included. TriCombo pricing is being confirmed by the team.
Still have more specific concerns?
Free Discovery CallDiscuss your symptoms, previous treatments and goals with the London Cartilage Clinic team. TriCombo availability and pricing will be confirmed directly before treatment is arranged.